Shanghai Yizhong Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Shanghai Yizhong Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 688091.SS.
Shanghai Yizhong Pharmaceutical Co., Ltd., founded in 2009 and based in Shanghai, China, specializes in the research and development of anti-cancer drugs and related pharmaceutical solutions within China. A notable product among its developments is a specific formulation of paclitaxel, a potent chemotherapeutic agent used to treat tumors.
Can you invest in Shanghai Yizhong Pharmaceutical Co., Ltd.?
Yes. Shanghai Yizhong Pharmaceutical Co., Ltd. trades publicly on SHH as 688091.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai Yizhong Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.